REGULATION OF ENHANCER OF ZESTE HOMOLOG 2 AND SIRTUIN-3 MEDIATES THE TUMOR PHENOTYPE IN PANCREATIC ADENOCARCINOMA

被引：0
|
作者：
Urayama, Shiro
Habib, Asad
Alzofon, Nathaniel
Wang, Shengzhou
机构：
来源：
GASTROENTEROLOGY | 2017年 / 152卷 / 05期
关键词：
D O I：
10.1016/S0016-5085(17)31220-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1322
引用
收藏
页码：S276 / S276
页数：1
相关论文
共 50 条
  • [21] microRNA-101 inhibits lung cancer invasion through the regulation of enhancer of zeste homolog 2
    Cho, Hyun Min
    Jeon, Hyo Sung
    Lee, Soo Young
    Jeong, Kang Jin
    Park, Soon-Young
    Lee, Hoi Young
    Lee, Jung Uee
    Kim, Ji Hye
    Kwon, Sun Jung
    Choi, Eugene
    Na, Moon Jun
    Kang, Jaeku
    Son, Ji Woong
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2011, 2 (05) : 963 - 967
  • [22] Decreased miR-124 contributes to the epithelial-mesenchymal transition phenotype formation of lung adenocarcinoma cells via targeting enhancer of zeste homolog 2
    Wu, Jian
    Li, Lingling
    Zhang, Yi
    Zhu, Jianjun
    PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (06)
  • [23] Enhancer of zeste homolog 2 (EZH2) regulates tumor angiogenesis and predicts recurrence and prognosis of intrahepatic cholangiocarcinoma
    Nakagawa, Shigeki
    Okabe, Hirohisa
    Ouchi, Mayuko
    Tokunaga, Ryuma
    Umezaki, Naoki
    Higashi, Takaaki
    Kaida, Takatoshi
    Arima, Kota
    Kitano, Yuki
    Kuroki, Hideyuki
    Mima, Kosuke
    Nitta, Hidetoshi
    Imai, Katsunori
    Hashimoto, Daisuke
    Yamashita, Yo-ichi
    Chikamoto, Akira
    Baba, Hideo
    HPB, 2018, 20 (10) : 939 - 948
  • [24] Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis
    Au, Sandy Leung-Kuen
    Wong, Carmen Chak-Lui
    Lee, Joyce Man-Fong
    Fan, Dorothy Ngo-Yin
    Tsang, Felice Hoching
    Ng, Irene Oi-Lin
    Wong, Chun-Ming
    HEPATOLOGY, 2012, 56 (02) : 622 - 631
  • [25] Potential of enhancer of zeste homolog 2 inhibitors for the treatment of SWI/SNF mutant cancers and tumor microenvironment modulation
    Pyziak, Karolina
    Sroka-Porada, Agnieszka
    Rzymski, Tomasz
    Dulak, Jozef
    Loboda, Agnieszka
    DRUG DEVELOPMENT RESEARCH, 2021, 82 (06) : 730 - 753
  • [26] Hyperhomocysteinemia in ApoE-/- Mice Leads to Overexpression of Enhancer of Zeste Homolog 2 via miR-92a Regulation
    Yang Xiaoling
    Zhao Li
    Li ShuQiang
    Ma Shengchao
    Yang Anning
    Ding Ning
    Li Nan
    Jia Yuexia
    Yang Xiaoming
    Li Guizhong
    Jiang Yideng
    PLOS ONE, 2016, 11 (12):
  • [27] Statins inhibit tumor progression via an enhancer of zeste homolog 2-mediated epigenetic alteration in colorectal cancer
    Ishikawa, S.
    Hayashi, H.
    Kinoshita, K.
    Abe, M.
    Kuroki, H.
    Tokunaga, R.
    Tomiyasu, S.
    Tanaka, H.
    Sugita, H.
    Arita, T.
    Yagi, Y.
    Watanabe, M.
    Hirota, M.
    Baba, H.
    INTERNATIONAL JOURNAL OF CANCER, 2014, 135 (11) : 2528 - 2536
  • [28] Inhibitors of enhancer of zeste homolog 2 (EZH2) activate tumor-suppressor microRNAs in human cancer cells
    Hibino, S.
    Saito, Y.
    Muramatsu, T.
    Otani, A.
    Kasai, Y.
    Kimura, M.
    Saito, H.
    ONCOGENESIS, 2014, 3 : e104 - e104
  • [29] Inhibitors of enhancer of zeste homolog 2 (EZH2) activate tumor-suppressor microRNAs in human cancer cells
    S Hibino
    Y Saito
    T Muramatsu
    A Otani
    Y Kasai
    M Kimura
    H Saito
    Oncogenesis, 2014, 3 : e104 - e104
  • [30] The polycomb group protein enhancer of zeste homolog 2 (EZH2) is an oncogene that influences myeloma cell growth and the mutant ras phenotype
    Paula A Croonquist
    Brian Van Ness
    Oncogene, 2005, 24 : 6269 - 6280
12345